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Summary dromic hearing loss (ADNSHL) is one of late-onset, pro-
gressive sensorineural hearing impairment (Van Camp
Nonsyndromic hearing loss (NSHL) is the most com- et al. 1997). Although advancing age is invariably asso-
mon type of hearing impairment in the elderly. Environ- ciated with a decline in auditory acuity so that Ç50%
mental and hereditary factors play an etiologic role, al- of octogenarians have a hearing loss ú25 dB (Morton
though the relative contribution of each is unknown. 1991), the relative contribution of ADNSHL to this
To date, 39 NSHL genes have been localized. Twelve prevalence ﬁgure is unknown.
produce autosomal dominant hearing loss, most fre- In this article, we describe a large multigenerational
quently postlingual in onset and progressive in nature. nonconsanguineous American kindred of northern Eu-
We have ascertained a large, multigenerational family ropean extraction in which persons with hearing impair-
in which a gene for autosomal dominant NSHL is segre- ment experience progressive, postlingual hearing impair-
gating. Affected individuals experience progressive hear- ment beginning in the mid-frequencies and slowly
ing loss beginning in the 2d–4th decades, eventually progressing to all frequencies. All affected persons re-
making the use of ampliﬁcation mandatory. A novel quire bilateral ampliﬁcation for effective communica-
locus, DFNA13, was identiﬁed on chromosome 6p; the tion.
disease gene maps to a 4-cM interval ﬂanked by
D6S1663 and D6S1691, with a maximum two-point
Patients, Material, and MethodsLOD score of 6.409 at D6S299.
Family Data
The family in this study was ascertained through theIntroduction
University of Iowa Department of Otolaryngology—
Inherited hearing impairment can be classiﬁed as syn- Head and Neck Surgery. Family history was obtained by
dromic or nonsyndromic, reﬂecting the presence or ab- questionnaire and telephone interviews. Medical records
sence of inherited physical abnormalities, respectively. and audiograms were reviewed, and blood samples were
To date, 12 dominant, 17 recessive, 8 X-linked, and 2 collected from all consenting individuals (27) (ﬁg. 1).
mitochondrial loci for nonsyndromic hearing loss have
Genotypingbeen identiﬁed (Van Camp et al. 1997). Numbered se-
quentially on the basis of time of discovery, dominant Genomic DNA was extracted from whole blood by
following a standard protocol (Grimberg et al. 1989),loci carry the preﬁx DFNA, recessive loci the preﬁx
DFNB, and X-linked loci the preﬁx DFN.Mitochondrial quantitated by spectrophotometric readings at optical
density260 , and diluted to 30 ng/ml for ampliﬁcation bymutations are designated by the site of the mutation
(e.g., A1555G, T7445C). PCR. After testing the family for linkage to the known
ADNSHL and ARNSHL (autosomal recessive) loci (VanWith the exception of single families linked to DFNA3
(Chaib et al. 1994), DFNA8 (Kirschhofer et al. 1996), Camp et al. 1997), short tandem repeat polymorphism
(STRP) screening set version 6, developed from markersand DFNA12 (Verhoeven et al. 1997), the typical phe-
notype of persons with autosomal dominant nonsyn- generated by the Cooperative Human Linkage Center
and made available through Research Genetics Inc., was
used to screen the remainder of the genome (Shefﬁeld
et al. 1995).Received June 4, 1997; accepted for publication July 22, 1997.
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Figure 1 Pedigree of DFNA13 family demonstrating the segregation of STRPs on 6p. Flanking markers are D6S1663 and D6S1691, as
deﬁned by crossovers in individuals IV-10 and II-5. A double crossover at D6S1663 occurred in individual IV-10 and has been inherited by
his affected offspring. (For individuals I-1, I-2, II-1 and II-3 to II-8, haplotypes are reconstructed;  Å male;  Å female;  Å affected male).
mented with 1 ml S35-dATP; 7.5 pmol of forward and gene was set at 0.001, and the disease was assumed to
be fully penetrant and dominant.reverse primers; 0.2 U Taq polymerase; and the remain-
der, ddH2O. Twenty-ﬁve cycles of ampliﬁcation were
completed at 94C for 30 s, 55C for 30 s, and 72C for
Results30 s. Reaction products were resolved on 6% denaturing
polyacrylamide gels (7.7M urea) and visualized by auto-
Disease Phenotyperadiography.
Persons with hearing impairment in this kindred typi-
LOD Score Calculations cally have a bilateral moderate-to-severe sensorineural
loss. With the exception of individual V-1, affected per-LOD scores were calculated using FASTLINK (Cot-
tingham et al. 1993). The frequency of the DFNA13 sons areú20 years of age; all are otherwise healthy, with
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Table 1 10–16-cM region ﬂanked by D6S109 and D6S306 (Gri-
gorenko et al. 1997), completely encompassing the
Two-Point Linkage Results Showing Zmax and u smaller 4-cM DFNA13 interval.
Two genes have been mapped to the region that maySTRP Zmax u
play a role in auditory function. The ﬁrst, COL11A2,
D6S1653 .140 2.154 localizes to 6p21.3 (Hanson et al. 1989) near the proxi-
D6S259 .304 .411 mal border of the HLA II region and is associated with
D6S288 .111 3.753
a unique Stickler syndrome phenotype characterized byD6S422 .041 4.917
hearing impairment and cartilaginous defects of the faceD6S1665 .040 5.431
D6S1663 .040 4.699 and extremities (Brunner et al. 1994). The other two
D6S1660 .001 5.400 chains of the type XI collagen heterotrimer, COL11A1
D6S299 .001 6.409 and COL11A3, map to 1p21 and 12q14.3, respectively
D6S1554 .001 5.970
(COL11A3 is not encoded by a separate gene but isD6S1691 .075 4.840
believed to be a heavily glycosylated form of COL2A1)D6S258 .000 4.911
D6S273 .053 3.808 (Hanson et al. 1989). In contrast to the classic Stickler
phenotype, lack of ophthalmological involvement in
persons with the COL11A2 defect reﬂects the absence of
COL11A2 in the vitreous (Brunner et al. 1994). Hearing
normal life spans and no dystrophic features, learning impairment is most commonly a mild-to-severe sensori-
disorders, or other abnormal ﬁndings. neural loss that slowly progresses to involve all frequen-
cies (Brunner et al. 1994). Just as mutations in the genesExclusion Analysis
for collagen types I and II cause a spectrum of pheno-
Linkage to the known ADNSHL and ARNSHL loci
types, allelic mutations in the COL11A2 gene may cause
was excluded (LOD scores õ02.0) by two-point analy-
hearing impairment in individuals with DFNA13. A pos-
sis using the MLINK program package. Approximately
sible animal model of the disease is the mouse mutant
180 markers then were tested before a signiﬁcant LOD
chondrodysplasia (cho). The homozygote phenotype is
score (ú3.0) was obtained with D6S422. Using STRPs
characterized by disproportionately shortened limbs,
tightly linked to this locus, the DFNA13 interval was
shortened head, protruding tongue, cleft palate, short
shown to be ﬂanked by D6S1663 and D6S1691 and to
mandible, and neonatal lethality caused by asphyxia due
span a 4-cM interval. A maximum two-point LOD score
to defective tracheal rings (Lyon and Searle 1990).
of 6.409 was obtained with D6S299 (table 1).
The second gene mapped to 6p21, OTF3, is a tran-
scription factor containing a POU domain (Guillaudeux
Discussion
et al. 1993). At least ﬁve POU-domain genes are ex-
pressed in the cochlea of the developing rat, and in theThe 4-cM interval to which the DFNA13 locus has
been mapped is ﬂanked by STRPs D6S1663 and human POU3F4 is responsible for the X-linked form of
congenital hearing impairment, DFN3 (de Kok et al.D6S1691 and is tightly linked to the HLA class II region
on chromosome 6p (Hanson et al. 1989) (ﬁg. 1). This 1995). The DFN3 phenotype is characterized by a pro-
gressive mixed loss, the conductive component of whichregion has been intensely studied, with ú40 human dis-
eases reported to share a genetic predisposition with is caused by stapes ﬁxation (de Kok et al. 1996).
Also relevant as a positional candidate is a cochlear-speciﬁc HLA II alleles (Cao et al. 1996). Relevant within
this group of diseases, by virtue of an association with derived expressed sequence tag (EST) that has been
mapped to this region (http://www.ncbi.nlm.nih.gov/).hearing impairment, are otosclerosis, Me´nie`re disease,
sudden sensorineural hearing loss, and progressive sen- This sequence can be extended to Ç2,000 bp by cyber-
screening of genetic databases such as dBest usingsorineural hearing loss (Cao et al. 1996), suggesting that
there may be important genes within the HLA II region BLAST. Although this EST must be characterized and
screened for mutations, previous work suggests thatthat affect hearing. This hypothesis is made more attrac-
tive by the localization of DFNA13 to the region. there are likely to be several genes expressed in the co-
chlea within the currently deﬁned region (Greinwald etAlso of interest, because of the possible interrelation-
ship between auditory perception and reading, is the al., in press). Because of the magnitude of work involved
in identifying, characterizing, and screening these candi-linkage of a quantitative trait locus for reading disability
to chromosome 6p21.3 (Cardon et al. 1994), a genomic dates, an alternative approach is to reﬁne the candidate
region by extending the pedigree. The large size of theregion originally targeted because of a hypothesized as-
sociation between autoimmune disease and dyslexia DFNA13 kindred will permit us to adopt this strategy to
reduce the 4-cM DFNA13 region to a more manageable(Geschwind and Galaburda 1985). Further work on dys-
lexic families has placed the dyslexia gene within the interval.
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